| Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect S Kalra, A Jain, J Ved, AG Unnikrishnan Indian journal of endocrinology and metabolism 20 (5), 725, 2016 | 61 | 2016 |
| Package inserts in India: need for a revision JK Ved International Journal of Pharma Sciences and Research 1 (11), 454-6, 2010 | 41 | 2010 |
| Benefits of Telemedicine and Barriers to its Effective Implementation in Rural India: A Multicentric E-Survey. CJ Ghia, JK Ved, RK Jha | 24 | 2013 |
| Basic and clinical pharmaco-therapeutics of SGLT2 inhibitors: a contemporary update S Kalra, KK Shetty, VB Nagarajan, JK Ved Diabetes Therapy 11, 813-833, 2020 | 20 | 2020 |
| Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient setting S Ghosal, B Sinha, J Ved, M Biswas Indian Heart Journal 72 (2), 119-122, 2020 | 12 | 2020 |
| Diabetes destiny in our hands: Achieving metabolic karma S Kalra, J Ved, MP Baruah Indian journal of endocrinology and metabolism 21 (3), 482, 2017 | 11 | 2017 |
| Indian guidance on cardiovascular and renal comorbidity management in type-2 diabetes mellitus AK Das, AG Unnikrishnan, B Saboo, V Mohan, V Vijay Journal of The Association of Physicians of India, 7, 2018 | 5 | 2018 |
| Role of Non Stress Test in Monitoring High Risk Pregnancy. A Biswas, M d Walliullah, S Biswas, AK Mukhopadhyay, CJ Ghia, JK Ved | 5 | 2013 |
| Pharmaceutical advertisements in Indian scientific journals: Analysis of completeness of information content JK Ved, SS Jagtiani, KA Chitnis Int J Pharma Sci Res 1, 366-70, 2010 | 4 | 2010 |
| Sodium-glucose cotransporter 2 inhibitor use: a pharmaco-ergonomic qualification tool S Kalra, AG Unnikrishnan, M Baruah, P Kawatra, J Ved Indian journal of endocrinology and metabolism 21 (5), 762, 2017 | 3 | 2017 |
| Reverse causality in Empa-Reg outcome: the proverbial elephant? R Rajput, J Ved Diabetes Research and Clinical Practice 127, 288-289, 2017 | 3 | 2017 |
| Clinical Pharmacology of Alpha-1 Blockers Improving Drug-profile through Novel Formulations. RP Nerurkar, JK Ved The Journal of the Association of Physicians of India 62 (9 Suppl), 9-12, 2014 | 3 | 2014 |
| Vasculo-metabolic Axis in Type 2 Diabetes Mellitus—Abductive Reasoning from Sodium-glucose Cotransporter 2-inhibitor Evidence J Ved, K Paul, S Kalra US Endocrinology 15 (1), 27-31, 2019 | 2 | 2019 |
| SGLT2-inhibitors in type-2 diabetes: The remaining questions! R Rajput, J Ved Diabetes & Metabolic Syndrome: Clinical Research & Reviews 11, S433-S438, 2017 | 2 | 2017 |
| Evaluation of cardioprotective effect of metformin in isoproterenol induced myocardial injury in rats KA Bhave, PR Pandit, J Ved, G Amonkar Indian Journal of Physiology and Pharmacology 60 (4), 392-402, 2016 | 2 | 2016 |
| Drug Prescribing Patterns During Antenatal Care in a Tertiary Care Rural Teaching Hospital: A Cross-Sectional Study CJ Ghia, S Gajbhiye, L Khobragade, JK Ved, GS Rambhad International Journal of Pharmaceutical Sciences and Research 5 (11), 4948, 2014 | 2 | 2014 |
| Alpha-blockers in renal disease: appraisal of evidence N Gopalakrishnan, R Sakthirajan, T Dineshkumar J Assoc Physicians India 62 (Suppl), 34-39, 2014 | 2 | 2014 |
| SGLT2-inhibition and Vascular Euphoria a Reconciliation of Vascular Health and Disease Homeostasis. M Tiwaskar, S Kalra, G Bantwal, A Bhattacharya, M Sahay, U Jadhav, ... The Journal of the Association of Physicians of India 69 (4), 11-12, 2021 | 1 | 2021 |
| Commentary on STOP DIABETES study V Suvarna, J Ved Perspectives in clinical research 10 (1), 42, 2019 | 1 | 2019 |
| Age and the Immune System CJ Ghia, M Naik, J Ved, G Rambhad The Journal of the Association of Physicians of India 63 (4 Suppl), 17-18, 2015 | 1 | 2015 |
